Most Recent
Australia's financial regulator is seeking to have top executives and directors of IOOF disqualified from acting as superannuation trustees, the watchdog said Friday, as Shine Lawyers revealed it has been investigating a possible class action against the financial services firm for a year.
Hastie Group's liquidators have offered to drop their $124 million case against two dozen major builders if the companies agree to pay an undisclosed sum toward their unpaid bills, a court heard Friday.
The Construction, Forestry, Maritime, Mining and Energy union has lost its bid to be heard by the High Court of Australia after an appeals court upheld a $306,000 fine for the illegal conduct of its former Queensland president and warned of the prospect of deregistration.
Former Reserve Bank of Australia official Christian Boillot was sentenced Thursday to a two and a half years' suspended jail term over his role in a conspiracy to bribe foreign officials to win banknote business.
Ramsay Health Care has defeated a challenge to its Nuramel trade mark for a brand of infant formula, with IP Australia saying while the mark was an exact anagram of Biofarma's Munarel, it wasn't deceptively similar.
ANZ treasurer Rick Moscati was at the centre of a flurry of phone calls and meetings with underwriters and other bank executives on the day the underwriters agreed to pick up a $791 million shortfall in a $2.5 billion capital raising, an agreement which has led to groundbreaking cases by two regulators, according to a new court document.
AMP's advice executive Jack Regan, the witness who aired the firm's fees-for-no-service dirty laundry at the Royal Commission, has retired, a day before five law firms compete to lead a class action over the scandal.
Internet provider Activ8me is in hot water with the consumer regulator for a second time this year, facing court action over allegedly false and misleading claims about the cost, speed and data limits of its internet packages.
Medical device maker B. Braun Melsungen is appealing a ruling that invalidated its intravenous catheter patents and dismissed allegations of infringement against rival Becton Dickinson.
A chain of cosmetic surgery clinics has lost its fight to have a class action of over 200 patients allegedly injured by botched breast augmentation surgery discontinued as a representative proceeding.